FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004199980> ?p ?o ?g. }

• W2004199980 endingPage "365" @default.
• W2004199980 startingPage "362" @default.
• W2004199980 abstract "<h3>Background</h3> Interstitial lung disease (ILD) is a progressive fibrotic disease of the lung parenchyma. It is the only complication of rheumatoid arthritis (RA) reported to be increasing, accounting for around 7% of all RA deaths.¹ Prognosis of patients with RA-ILD is reported to be poor, with usual interstitial pneumonia (UIP) being the predominant pattern associated with poor survival.² It is a challenge to determine specific pattern of ILD and formulate an appropriate treatment plan to achieve stabilisation. Early use of Methotrexate (MTX) and biologics in RA has improved outcomes and quality of life. However, this causes difficulty when RA patients develop ILD. There are reports of ILD with biologics and DMARDs, although it is difficult to establish a causal relationship or if an exacerbation of pre-existing ILD. There are no evidence based guidelines regarding introducing biologics in such patients and clinicians face a dilemma as to whether they should be denied. <h3>Objectives</h3> The aim of this retrospective study is to: Check the overall management of RA and ILD. Examine whether ILD diagnosis influences treatment of RA. <h3>Methods</h3> We reviewed 37 patients with RA-ILD from 3 hospitals (2001–2017). We collected data on demographics, clinical, Pulmonary function tests, imaging, time from diagnosis to treatment and outcomes. <h3>Results</h3> The majority developed ILD after RA except for 3 patients. Mean age of onset of RA was 67 years, 22 (60%) were female. 32 (87%) were RF or ACPA positive, 25 (68%) patients smoked. 29 (78%) patients had baseline PFTs. HRCT showed 13 had NSIP<b>,</b> 20 UIP and 4 were unclassified. Following the diagnosis of ILD, MTX was stopped in 16 patients, reduced in 3 and unchanged in 2. Leflunomide was stopped in 4 and SLZ stopped in 4, of which 1 had definite alveolitis. Infliximab was stopped in 2 patients. <h3>Specific Treatment for ILD</h3> 12 patients received Rituximab, of those 8 were for ILD and 4 for RA. 4 Patients continued Anti-TNF. 26 patients received steroids, 4 received MMF and 2 Cyclophosphamide. 2 received Abatacept for ILD with active RA and one received Etanercept. 3 were on Carbocysteine, 2 on NAC and 3 on oxygen. <h3>Outcomes</h3> 20 ILD patients were stable and 8 (21%) progressed and died despite treatment. RA disease activity was low to moderate in 23 patients. RA progressed in 8 patients and 1 who received Etanercept was in remission. MTX was stopped in the majority of patients. Steroids were the commonest treatment for RA in the presence of ILD. Rituximab was the drug of choice for RA with severe ILD, followed by MMF and Cyclophosphamide. DMARDs such as HCQ, Leflunomide and SLZ were used for RA in milder ILD and biologics were generally avoided. <h3>Conclusions</h3> There appears to be significant variation in the treatment of RA in the presence of ILD. However Rituximab seems to be the prefered option for severe ILD. There is a need for stratified and standardised guidance for management of RA-ILD. <h3>References</h3> [1] Bongartz T, Nannini C, Medina-Velasquez YF, et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum2010;62:1583–1591. [2] Solomon JJ, Ryu JH, Tazelaar HD, et al. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Respir Med2013;107:1247–1252. <h3>Disclosure of Interest</h3> None declared" @default.
• W2004199980 created "2016-06-24" @default.
• W2004199980 creator A5006531570 @default.
• W2004199980 creator A5042153155 @default.
• W2004199980 creator A5044806653 @default.
• W2004199980 date "1990-08-18" @default.
• W2004199980 modified "2023-09-25" @default.
• W2004199980 title "Symptoms of low blood pressure: a population study." @default.
• W2004199980 cites W1978867430 @default.
• W2004199980 cites W2006138743 @default.
• W2004199980 cites W2011919520 @default.
• W2004199980 cites W2023002737 @default.
• W2004199980 cites W2041528815 @default.
• W2004199980 cites W2074772121 @default.
• W2004199980 cites W2087063609 @default.
• W2004199980 cites W2091175790 @default.
• W2004199980 cites W2098163774 @default.
• W2004199980 cites W2106713670 @default.
• W2004199980 cites W2117032030 @default.
• W2004199980 cites W2148500695 @default.
• W2004199980 cites W4241539684 @default.
• W2004199980 doi "https://doi.org/10.1136/bmj.301.6748.362" @default.
• W2004199980 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1679910" @default.
• W2004199980 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2400856" @default.
• W2004199980 hasPublicationYear "1990" @default.
• W2004199980 type Work @default.
• W2004199980 sameAs 2004199980 @default.
• W2004199980 citedByCount "140" @default.
• W2004199980 countsByYear W20041999802012 @default.
• W2004199980 countsByYear W20041999802013 @default.
• W2004199980 countsByYear W20041999802014 @default.
• W2004199980 countsByYear W20041999802015 @default.
• W2004199980 countsByYear W20041999802016 @default.
• W2004199980 countsByYear W20041999802017 @default.
• W2004199980 countsByYear W20041999802018 @default.
• W2004199980 countsByYear W20041999802019 @default.
• W2004199980 countsByYear W20041999802020 @default.
• W2004199980 countsByYear W20041999802021 @default.
• W2004199980 countsByYear W20041999802022 @default.
• W2004199980 countsByYear W20041999802023 @default.
• W2004199980 crossrefType "journal-article" @default.
• W2004199980 hasAuthorship W2004199980A5006531570 @default.
• W2004199980 hasAuthorship W2004199980A5042153155 @default.
• W2004199980 hasAuthorship W2004199980A5044806653 @default.
• W2004199980 hasBestOaLocation W20041999801 @default.
• W2004199980 hasConcept C126322002 @default.
• W2004199980 hasConcept C159110408 @default.
• W2004199980 hasConcept C167135981 @default.
• W2004199980 hasConcept C177713679 @default.
• W2004199980 hasConcept C2777014857 @default.
• W2004199980 hasConcept C2777405647 @default.
• W2004199980 hasConcept C2777543607 @default.
• W2004199980 hasConcept C2777575956 @default.
• W2004199980 hasConcept C2777714996 @default.
• W2004199980 hasConcept C2779951463 @default.
• W2004199980 hasConcept C2780132546 @default.
• W2004199980 hasConcept C2908647359 @default.
• W2004199980 hasConcept C71924100 @default.
• W2004199980 hasConcept C99454951 @default.
• W2004199980 hasConceptScore W2004199980C126322002 @default.
• W2004199980 hasConceptScore W2004199980C159110408 @default.
• W2004199980 hasConceptScore W2004199980C167135981 @default.
• W2004199980 hasConceptScore W2004199980C177713679 @default.
• W2004199980 hasConceptScore W2004199980C2777014857 @default.
• W2004199980 hasConceptScore W2004199980C2777405647 @default.
• W2004199980 hasConceptScore W2004199980C2777543607 @default.
• W2004199980 hasConceptScore W2004199980C2777575956 @default.
• W2004199980 hasConceptScore W2004199980C2777714996 @default.
• W2004199980 hasConceptScore W2004199980C2779951463 @default.
• W2004199980 hasConceptScore W2004199980C2780132546 @default.
• W2004199980 hasConceptScore W2004199980C2908647359 @default.
• W2004199980 hasConceptScore W2004199980C71924100 @default.
• W2004199980 hasConceptScore W2004199980C99454951 @default.
• W2004199980 hasIssue "6748" @default.
• W2004199980 hasLocation W20041999801 @default.
• W2004199980 hasLocation W20041999802 @default.
• W2004199980 hasLocation W20041999803 @default.
• W2004199980 hasLocation W20041999804 @default.
• W2004199980 hasOpenAccess W2004199980 @default.
• W2004199980 hasPrimaryLocation W20041999801 @default.
• W2004199980 hasRelatedWork W1540919331 @default.
• W2004199980 hasRelatedWork W1980580462 @default.
• W2004199980 hasRelatedWork W1998480796 @default.
• W2004199980 hasRelatedWork W2088333802 @default.
• W2004199980 hasRelatedWork W2377651479 @default.
• W2004199980 hasRelatedWork W3024842914 @default.
• W2004199980 hasRelatedWork W3096776997 @default.
• W2004199980 hasRelatedWork W4205917269 @default.
• W2004199980 hasRelatedWork W4285022406 @default.
• W2004199980 hasRelatedWork W4311448369 @default.
• W2004199980 hasVolume "301" @default.
• W2004199980 isParatext "false" @default.
• W2004199980 isRetracted "false" @default.
• W2004199980 magId "2004199980" @default.
• W2004199980 workType "article" @default.